Gilead Sciences Inc banner

Gilead Sciences Inc
XBER:GIS

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
XBER:GIS
Watchlist
Price: 127 EUR 20.08% Market Closed
Market Cap: €158.2B

Wall St Price Targets

GIS Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GIS is 160.34 EUR with a low forecast of 122.37 EUR and a high forecast of 187.7 EUR.

Lowest Forecast
Price Target
122.37 EUR
4% Downside
Average Forecast
Price Target
160.34 EUR
26% Upside
Highest Forecast
Price Target
187.7 EUR
48% Upside
Gilead Sciences Inc Competitors:
Price Targets
FULT
Fulton Financial Corp
-1% Downside
PTEN
Patterson-UTI Energy Inc
43% Upside
NCSM
NCS Multistage Holdings Inc
58% Upside

Revenue
Forecast

9% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 8%.

Operating Income
Forecast

8% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
8% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 13%.

Pre-Tax Income
Forecast

8% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
8% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.

Net Income
Forecast

10% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss
10% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GIS's stock price target?
Price Target
160.34 EUR

According to Wall Street analysts, the average 1-year price target for GIS is 160.34 EUR with a low forecast of 122.37 EUR and a high forecast of 187.7 EUR.

What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 13%.

What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett